Gαi2 signaling is required for skeletal muscle growth, regeneration, and satellite cell proliferation and differentiation

Molecular and Cellular Biology

Volumn 34, Issue 4, 2014, Pages 619-630

  Minetti, Giulia C ^a   Feige, Jerome N ^b   Bombard, Florian ^a   Heier, Annabelle ^a   Morvan, Fredric ^a   Nürnberg, Bernd ^c   Leiss, Veronika ^c   Birnbaumer, Lutz ^d   Glass, David J ^e   Fornaro, Mara ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b EPFL   (Switzerland)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^e NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTOXIN; GAG PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE DEACETYLASE; MICRORNA; MICRORNA 1; MICRORNA 206; MICRORNA 27B; MYOD PROTEIN; MYOGENIC FACTOR 5; PROTEIN GALPHAI2; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE C IOTA; S6 KINASE; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MYH1; TRANSCRIPTION FACTOR MYH2; TRANSCRIPTION FACTOR MYH3; TRANSCRIPTION FACTOR MYH4; TRANSCRIPTION FACTOR MYH7; TRANSCRIPTION FACTOR MYH8; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EX VIVO STUDY; FEMALE; GENE EXPRESSION REGULATION; LEAN BODY WEIGHT; MALE; MOUSE; MUSCLE GROWTH; MUSCLE HYPERTROPHY; MUSCLE INJURY; MUSCLE REGENERATION; MYOBLAST; MYOTUBE; NONHUMAN; POSTNATAL GROWTH; PRIORITY JOURNAL; REGULATORY MECHANISM; SKELETAL MUSCLE SATELLITE CELL;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; GTP-BINDING PROTEIN ALPHA SUBUNIT, GI2; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOBLASTS; REGENERATION; SATELLITE CELLS, SKELETAL MUSCLE; SIGNAL TRANSDUCTION;

EID: 84893019463     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00957-13     Document Type: Article

References (29)

1. Wettschureck N, Offermanns S. 2005. Mammalian G proteins and their cell type specific functions. Physiol. Rev. 85:1159-1204. http://dx.doi.org /10.1152/physrev.00003.2005.
2. Pineda VV, Athos JI, Wang H, Celver J, Ippolito D, Boulay G, Birnbaumer L, Storm DR. 2004. Removal of G(ialpha1) constraints on adenylyl cyclase in the hippocampus enhances LTP and impairs memory formation. Neuron 41:153-163. http://dx.doi.org/10.1016/S0896-6273(03)00813-4.
3. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, Boulay G, Bradley A, Birnbaumer L. 1995. Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat. Genet. 10:143-150. http://dx.doi.org/10.1038/ng0695-143.
4. Zuberi Z, Birnbaumer L, Tinker A. 2008. The role of inhibitory heterotrimeric G proteins in the control of in vivo heart rate dynamics. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295:R1822-R1830. http://dx.doi .org/10.1152/ajpregu.90625.2008.
5. Gohla A, Klement K, Nurnberg B. 2007. The heterotrimeric G protein G(i3) regulates hepatic autophagy downstream of the insulin receptor. Autophagy 3:393-395.
6. Plummer NW, Spicher K, Malphurs J, Akiyama H, Abramowitz J, Nurnberg B, Birnbaumer L. 2012. Development of the mammalian axial skeleton requires signaling through the Galpha(i) subfamily of heterotrimeric G proteins. Proc. Natl. Acad. Sci. U. S. A. 109:21366-21371. http: //dx.doi.org/10.1073/pnas.1219810110.
7. Ezan J, Lasvaux L, Gezer A, Novakovic A, May-Simera H, Belotti E, Lhoumeau AC, Birnbaumer L, Beer-Hammer S, Borg JP, Le Bivic A, Nurnberg B, Sans N, Montcouquiol M. 2013. Primary cilium migration depends on G-protein signalling control of subapical cytoskeleton. Nat. Cell Biol. 15:1107-1115. http://dx.doi.org/10.1038/ncb2819.
8. Wang YX, Rudnicki MA. 2012. Satellite cells, the engines of muscle repair. Nat. Rev. Mol. Cell Biol. 13:127-133. http://dx.doi.org/10.1038 /nrm3265.
9. Cardasis CA, Cooper GW. 1975. An analysis of nuclear numbers in individual muscle fibers during differentiation and growth: a satellite cellmuscle fiber growth unit. J. Exp. Zool. 191:347-358. http://dx.doi.org/10 .1002/jez.1401910305.
10. Moss FP, Leblond CP. 1970. Nature of dividing nuclei in skeletal muscle of growing rats. J. Cell Biol. 44:459-462. http://dx.doi.org/10.1083/jcb.44 .2.459.
11. Minetti GC, Feige JN, Rosenstiel A, Bombard F, Meier V, Werner A, Bassilana F, Sailer AW, Kahle P, Lambert C, Glass DJ, Fornaro M. 2011. Galphai2 signaling promotes skeletal muscle hypertrophy, myoblast differentiation, and muscle regeneration. Sci. Signal. 4:ra80. http://dx.doi .org/10.1126/scisignal.2002038.
12. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, Bradley A, Birnbaumer L. 1995. Gi2 alpha protein deficiency: a model of inflammatory bowel disease. J. Clin. Immunol. 15:101S-105S. http://dx .doi.org/10.1007/BF01540899.
13. Wiege K, Ali SR, Gewecke B, Novakovic A, Konrad FM, Pexa K, Beer-Hammer S, Reutershan J, Piekorz RP, Schmidt RE, Nurnberg B, Gessner JE. 2013. Galphai2 is the essential Galphai protein in immune complex-induced lung disease. J. Immunol. 190:324-333. http://dx.doi .org/10.4049/jimmunol.1201398.
14. Bischoff R, Heintz C. 1994. Enhancement of skeletal muscle regeneration. Dev. Dyn. 201:41-54. http://dx.doi.org/10.1002/aja.1002010105.
15. d'Albis A, Couteaux R, Janmot C, Roulet A, Mira JC. 1988. Regeneration after cardiotoxin injury of innervated and denervated slow and fast muscles of mammals. Myosin isoform analysis. Eur. J. Biochem. 174:103- 110. http://dx.doi.org/10.1111/j.1432-1033.1988.tb14068.x.
16. Whalen RG, Harris JB, Butler-Browne GS, Sesodia S. 1990. Expression of myosin isoforms during notexin-induced regeneration of rat soleus muscles. Dev. Biol. 141:24-40. http://dx.doi.org/10.1016/0012-1606(90)90099-5.
17. Sartore S, Gorza L, Schiaffino S. 1982. Fetal myosin heavy chains in regenerating muscle. Nature 298:294-296. http://dx.doi.org/10.1038 /298294a0.
18. Schiaffino S, Sandri M, Murgia M. 2007. Activity-dependent signaling pathways controlling muscle diversity and plasticity. Physiology 22:269- 278. http://dx.doi.org/10.1152/physiol.00009.2007.
19. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ. 2006. The role of microRNA-1 and microRNA- 133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38: 228-233. http://dx.doi.org/10.1038/ng1725.
20. Kim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A. 2006. Musclespecific microRNA miR-206 promotes muscle differentiation. J. Cell Biol. 174:677-687. http://dx.doi.org/10.1083/jcb.200603008.
21. Koutsoulidou A, Mastroyiannopoulos NP, Furling D, Uney JB, Phylactou LA. 2011. Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle. BMC Dev. Biol. 11:34. http://dx.doi.org/10.1186/1471-213X-11-34.
22. Iezzi S, Di Padova M, Serra C, Caretti G, Simone C, Maklan E, Minetti G, Zhao P, Hoffman EP, Puri PL, Sartorelli V. 2004. Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev. Cell 6:673-684. http://dx.doi .org/10.1016/S1534-5807(04)00107-8.
23. Minetti GC, Colussi C, Adami R, Serra C, Mozzetta C, Parente V, Fortuni S, Straino S, Sampaolesi M, Di Padova M, Illi B, Gallinari P, Steinkuhler C, Capogrossi MC, Sartorelli V, Bottinelli R, Gaetano C, Puri PL. 2006. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat. Med. 12:1147- 1150. http://dx.doi.org/10.1038/nm1479.
24. Chen EH, Olson EN. 2005. Unveiling the mechanisms of cell-cell fusion. Science 308:369-373. http://dx.doi.org/10.1126/science.1104799.
25. Pallafacchina G, Blaauw B, Schiaffino S. 22 May 2012. Role of satellite cells in muscle growth and maintenance of muscle mass. Nutr. Metab. Cardiovasc. Dis. http://dx.doi.org/10.1016/j.numecd.2012.02.002.
26. Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB, Richardson JA, Bassel-Duby R, Olson EN. 2007. An intragenic MEF2- dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc. Natl. Acad. Sci. U. S. A. 104:20844-20849. http://dx.doi.org/10 .1073/pnas.0710558105.
27. Rao PK, Kumar RM, Farkhondeh M, Baskerville S, Lodish HF. 2006. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc. Natl. Acad. Sci. U. S. A. 103:8721-8726. http://dx.doi.org/10.1073 /pnas.0602831103.
28. Consalvi S, Saccone V, Giordani L, Minetti G, Mozzetta C, Puri PL. 2011. Histone deacetylase inhibitors in the treatment of muscular dystrophies: epigenetic drugs for genetic diseases. Mol. Med. 17:457-465. http: //dx.doi.org/10.2119/molmed.2011.00049.
29. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ. 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat. Cell Biol. 3:1009-1013. http://dx.doi.org/10.1038/ncb1101 -1009.